ClinicalTrials.gov
public full text
Public Domain
A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)
This is a randomized, double-blind, placebo-controlled Phase 2/3 study to evaluate the efficacy, safety, and antiviral activity of CP-COV03 in adult patients with dengue infection.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Therapeutic approaches against dengue virus: current status of vaccines, antivirals, and monoclonal antibodies.#309484
- Therapeutic approaches against dengue virus: current status of vaccines, antivirals, and monoclonal antibodies.#308932
- A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults#201605
- Comparative analysis of response to selection with three insecticides in the dengue mosquito Aedes aegypti using mRNA sequencing#317424
- Anti-dengue fever activity of a polyherbal extract from medicinal plants of Vietnam#425847
Record · ID 870119
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive